This week regular guest host Dr Anna Volkmer talks with the joint co-ordinating editors of the Cochrane Dementia Group. Listen to hear about the work of Cochrane, how they support evidence-informed decision making in healthcare, their work on undertaking systematic reviews and how you could become involved.

This weeks guests are:

Dr Terry Quinn, Clinical Senior Lecturer, Honorary Consultant and Joint co-ordinating editor of Cochrane Dementia Group. Terry is a clinician working in stroke and older adult services in Glasgow is also the national lead for ageing research in Scotland.

Dr Jenny McCleery, Consultant Psychiatrist & Joint co-ordinating editor of Cochrane who describes herself as first, and foremost a Clinician. In her day-job she works as part of a community team for Older Adults at Oxfordshire Health NHS Foundation Trust.

Cochrane Dementia and Cognitive Improvement Group, is part of Cochrane’s Mental Health and Neuroscience Network. They aim is to provide the highest quality evidence about the care and medical treatment of people with dementia, delirium and other cognitive disorders, and about the diagnosis and prevention of these disorders. This is done through undertaking systematic reviews addressing questions which are important to patients, their families, and healthcare professionals from all disciplines.

_________________________

You can read more about the scope of Cochrane Dementia and their work here:

https://dementia.cochrane.org/our-work

A transcript of this podcast is also available here

https://www.dementiaresearcher.nihr.ac.uk/podcast-cochrane-dementia-and-cognitive-improvement-group

Dr Terry Quinn Bio

https://www.dementiaresearcher.nihr.ac.uk/profile-dr-terry-quinn/

Dr Jenny McCleery Bio

https://www.dementiaresearcher.nihr.ac.uk/profile-dr-jenny-mccleery/

_________________________

Register on our website to receive your weekly bulletin, and to access more great content – blogs, science, career support + much more

https://www.dementiaresearcher.nihr.ac.uk

This podcast is brought to you in association with Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.